# Zepbound: what it is, and the honest evidence

> What Zepbound actually is: the molecule (tirzepatide, a dual GLP-1/GIP agonist), its FDA-approved weight-management and sleep-apnea uses, how it differs from Mounjaro and Wegovy, and honest, evidence-graded answers on results, side effects, and myths.

**Type:** Brand hub · **Molecule:** tirzepatide · **Maker:** Eli Lilly · **Source page:** https://thepeptideera.com/zepbound

## At a glance
Zepbound is a brand name for tirzepatide, a dual GLP-1 and GIP receptor agonist made by Eli Lilly and FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity. It is the same molecule as Mounjaro, which carries the type 2 diabetes indication. In the head-to-head SURMOUNT-5 trial, tirzepatide produced more weight loss than semaglutide, though that was a single open-label study.

## Facts
- **Molecule:** tirzepatide
- **How it works:** a dual GLP-1 and GIP receptor agonist
- **Maker:** Eli Lilly
- **Form:** a once-weekly injection
- **FDA-approved for:** chronic weight management, and moderate-to-severe obstructive sleep apnea in adults with obesity
- **Sibling brand:** Mounjaro — the same molecule, approved for type 2 diabetes

## Evidence
- [Zepbound vs Wegovy: what the head-to-head evidence shows](https://thepeptideera.com/evidence/zepbound-vs-wegovy) — The head-to-head with semaglutide (Wegovy).
- [Mounjaro vs. Zepbound: same molecule, two different labels](https://thepeptideera.com/evidence/mounjaro-vs-zepbound) — Same molecule as Mounjaro — what actually differs.
- [Tirzepatide side effects: what the evidence actually shows](https://thepeptideera.com/evidence/tirzepatide-side-effects) — What the evidence shows about tirzepatide’s side effects.
- [GLP-1s and sleep: apnea, and the 'vivid dreams' question](https://thepeptideera.com/evidence/glp1-sleep) — The real, FDA-approved sleep-apnea benefit — and the "vivid dreams" claim.
- [What happens when you stop GLP-1 medications?](https://thepeptideera.com/evidence/stopping-glp1) — What the evidence says happens when you stop.
- [Keeping weight off after stopping a GLP-1](https://thepeptideera.com/evidence/keeping-weight-off-after-glp1) — Holding the result — the maintenance question.

## Myths, graded
- "Zepbound and Mounjaro are different drugs." — Same molecule — both are tirzepatide; the two brands exist because the drug is approved (and marketed) for different uses. (https://thepeptideera.com/myths/zepbound-mounjaro-different-drugs)
- "Tirzepatide is just a stronger version of Ozempic." — Partly true, oversimplified (https://thepeptideera.com/myths/tirzepatide-just-stronger)
- "You lose mostly muscle on GLP-1s, not fat." — Mostly false — you lose mostly fat, but some lean loss is real (https://thepeptideera.com/myths/mostly-muscle-loss)
- "You can just stop taking it once you hit your goal weight." — Misleading overstatement (https://thepeptideera.com/myths/stop-at-goal)
- "You have to take it forever — it's a life sentence." — Mostly true on the biology, loaded in the framing — obesity is chronic, so stopping usually brings regain (https://thepeptideera.com/myths/glp1-forever-life-sentence)

## Sources (4)
1. ZEPBOUND (tirzepatide) injection — FDA Prescribing Information (DailyMed) — https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b [LABEL]
2. FDA Approves New Medication for Chronic Weight Management (Zepbound, 2023) — https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management [NEWS]
3. FDA Approves First Medication for Obstructive Sleep Apnea (Zepbound, Dec 2024) — https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea [NEWS]
4. Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med. 2025. (Single open-label head-to-head; −20.2% tirzepatide vs −13.7% semaglutide at 72 weeks.) — https://www.nejm.org/doi/full/10.1056/NEJMoa2416394 [RCT]

---
From The Peptide Era (https://thepeptideera.com) — evidence-graded, primary-sourced answers about GLP-1 medicines. Education, not medical advice. Not a buying guide. No doses, no sourcing.